Ken Wilke's Email & Phone Number
Life Sciences Project Management, Strategy & Operations
Ken Wilke Email Addresses
Ken Wilke Phone Numbers
Ken Wilke's Work Experience
Orpro Therapeutics
Strategy & Operations Consultant
March 2020 to October 2020
BioStrategy Solutions, LLC
Founder / Principal
March 2014 to September 2019
Bristol-Myers Squibb
Director, Translational Medicine Strategy & Operations
March 2017 to September 2018
Director / Project Management Lead - Clinical Pharmacogenomics & Specimen Management
January 2011 to November 2013
Show more
Show less
Frequently Asked Questions about Ken Wilke
What is Ken Wilke email address?
Email Ken Wilke at [email protected]. This email is the most updated Ken Wilke's email found in 2024.
How to contact Ken Wilke?
To contact Ken Wilke send an email to [email protected].
What company does Ken Wilke work for?
Ken Wilke works for CBRE
What is Ken Wilke's role at CBRE?
Ken Wilke is Director
What is Ken Wilke's Phone Number?
Ken Wilke's phone (213) ***-*164
What industry does Ken Wilke work in?
Ken Wilke works in the Biotechnology industry.
Ken Wilke's Professional Skills Radar Chart
Based on our findings, Ken Wilke is ...
What's on Ken Wilke's mind?
Based on our findings, Ken Wilke is ...
Ken Wilke's Estimated Salary Range
Ken Wilke Email Addresses
Ken Wilke Phone Numbers
Find emails and phone numbers for 300M professionals.
Search by name, job titles, seniority, skills, location, company name, industry, company size, revenue, and other 20+ data points to reach the right people you need. Get triple-verified contact details in one-click.In a nutshell
Ken Wilke's Ranking
Ranked #873 out of 17,460 for Director in California
Ken Wilke's Personality Type
Extraversion (E), Sensing (S), Thinking (T), Perceiving (P)
Average Tenure
2 year(s), 0 month(s)
Ken Wilke's Willingness to Change Jobs
Unlikely
Likely
Open to opportunity?
There's 79% chance that Ken Wilke is seeking for new opportunities
Ken Wilke's Social Media Links
/in/ken-wilke-1977743 /school/lehigh-university/ /company/orpro-therapeutics